Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021–2023, and Characterization of Newly Emerged Virus Clades
Journal of Medical Virology · 2025-08 · 97 (8)
DOI: 10.1002/jmv.70530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 07.08.2025. Verfasst von Susanne Duwe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Robert Koch-Institute, Department 1: Infectious Diseases, Unit 17: Influenza and Other Respiratory Viruses, Berlin, Germany. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Influenza, Human. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the German Ministry of Health in the context of the nationwide surveillance of influenza and other respiratory viruses at the National…, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The first waves of the COVID‐19 pandemic were accompanied by an unprecedented decrease of influenza activity which persisted throughout the 2020/21 and 2021/22 winter seasons. Here, we report on the unusual influenza circulation patterns that followed in the year 2022, which was dominated throughout by A(H3N2) influenza viruses. After a delayed spring wave in 2022, A(H3N2) influenza viruses circulated at low levels throughout the summer and rose to a prominent, prematurely‐timed fall/winter wave peaking in December, with highest positivity rates observed in 10–12‐years old children. This winter wave ended abruptly with the national school holidays, when positivity rates decreased sharply not only in children but also in other age groups. Genetic analysis of influenza virus hemagglutinin (HA) showed cocirculation of 10 A(H3N2) clades, of which three (2a.1b, 2a.3a.1, and 2b) became dominant in late 2022. All A(H3N2) viruses, including those assigned to the new clades, displayed high titers in HA inhibition tests with postinfection ferret antiserum raised against the A(H3N2) vaccine strains A/Cambodia/e0826360/2020 and A/Darwin/9/2021. All viruses were susceptible to neuraminidase inhibitors and the polymerase inhibitor baloxavir marboxil, but carried the M2‐S31N substitution conferring adamantane resistance. Our findings shed light on disturbed seasonality of A(H3N2) circulation in the post‐COVID‐19 era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert Koch-Institute, Department 1: Infectious Diseases, Unit 17: Influenza and Other Respiratory Viruses, Berlin, Germany.
- Robert Koch-Institute, Project Group 5: Systems Medicine of Infectious Diseases, Berlin, Germany.
- Medizinisches Versorgungszentrum Labor 28 GmbH, Berlin, Germany.
- Department of Mathematics and Computer Science, Free University Berlin, Germany.
ORCID-Profile: Susanne Duwe, Djin-Ye Oh, Daniela Börnigen, Ralf Ignatius, Max von Kleist, Janine Reiche, Barbara Biere, Thorsten Wolff, Ralf Dürrwald
Förderung
- This study was funded by the German Ministry of Health in the context of the nationwide surveillance of influenza and other respiratory viruses at the National…
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Duwe, S., Oh, D. Y., Wedde, M., Börnigen, D., Ignatius, R., Kleist, M. V., Reiche, J., Biere, B., Wolff, T., & Dürrwald, R. (2025). Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021–2023, and Characterization of Newly Emerged Virus Clades. Journal of Medical Virology, 97(8). https://doi.org/10.1002/jmv.70530
Vancouver
Duwe S, Oh DY, Wedde M, Börnigen D, Ignatius R, Kleist MV, et al. Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021–2023, and Characterization of Newly Emerged Virus Clades. Journal of Medical Virology. 2025;97(8). doi:10.1002/jmv.70530
BibTeX
@article{Duwe2025,
author = {Duwe, Susanne and Oh, Djin-Ye and Wedde, Marianne and Börnigen, Daniela and Ignatius, Ralf and Kleist, Max von and Reiche, Janine and Biere, Barbara and Wolff, Thorsten and Dürrwald, Ralf},
title = {Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021–2023, and Characterization of Newly Emerged Virus Clades},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {8},
doi = {10.1002/jmv.70530}
}
EUVIMED